Consensus-based definition of unfitness to intensive and non-intensive chemotherapy in acute myeloid leukemia: a project of SIE, SIES and GITMO group on a new tool for therapy decision making-Reference-Cited by-同舟云学术

Consensus-based definition of unfitness to intensive and non-intensive chemotherapy in acute myeloid leukemia: a project of SIE, SIES and GITMO group on a new tool for therapy decision making

Published:2013-05 Issue:5 Volume:27 Page:997-999
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Ferrara F,Barosi G,Venditti A,Angelucci E,Gobbi M,Pane F,Tosi P,Zinzani P,Tura S

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/leu2012303.pdf

Reference15 articles.

1. Juliusson G, Lazarevic V, Hörstedt AS, Hagberg O, Höglund M, Swedish Acute Leukemia Registry Group. Acute myeloid leukemia in the real world: why population-based registries are needed. Blood 2012; 119: 3890–3899.

2. Ferrara F, Palmieri S, Leoni F . Clinically useful prognostic factors in acute myeloid leukemia. Crit Rev Oncol Hematol 2008; 66: 181–193.

3. Malfuson JV, Etienne A, Turlure P, de Revel T, Thomas X, Contentin N et al. Acute Leukemia French Association (ALFA). Risk factors and decision criteria for intensive chemotherapy in older patients with acute myeloid leukemia. Haematologica 2008; 93: 1806–1813.

4. Djunic I, Virijevic M, Novkovic A, Novkovic A, Colovic N, Kraguljac-Kurtovic N et al. Comorbidity as a risk factor for overall survival and decision criteria for intensity of chemotherapy in elderly patients with acute myeloid leukemia. Med Oncol 2012; 29: 1077–1081.

5. Morra E, Barosi G, Bosi A, Ferrara F, Locatelli F, Marchetti M et al. Clinical management of primary non-acute promyelocytic leukemia acute myeloid leukemia: Practice guidelines by the Italian Society of Hematology, the Italian Society of Experimental Hematology, and the Italian Group for Bone Marrow Transplantation. Haematologica 2009; 94: 102–112.

Cited by 115 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real-Life Management of FLT3-Mutated AML: Single-Centre Experience over 24 Years;Cancers;2024-08-17

2. Novel insights and therapeutic approaches in secondary AML;Frontiers in Oncology;2024-07-29

3. Treatment and clinical outcomes of patients with acute myeloid leukemia in Finland 2010–2020: A retrospective analysis of electronic health records;European Journal of Haematology;2024-07-29

4. Blood Cancer Network Ireland (BCNI) and National Cancer Registry Ireland (NCRI) collaboration: challenges and utility of an Enhanced Blood Cancer Outcomes Registry (EBCOR) pilot;Irish Journal of Medical Science (1971 -);2024-07-20

5. Frontline therapy of acute myeloid leukemia with lower intensity regimens: Where are we now and where can we go?;American Journal of Hematology;2024-07-17